DERM US and EU Validation Study

CompletedOBSERVATIONAL
Enrollment

1,111

Participants

Timeline

Start Date

March 15, 2022

Primary Completion Date

August 19, 2022

Study Completion Date

September 15, 2022

Conditions
Malignant Skin Melanoma T0Basal Cell CarcinomaSquamous Cell Carcinoma
Interventions
DEVICE

Deep Ensemble for the Recognition of Malignancy (DERM)

An AI-based diagnosis support tool

Trial Locations (16)

14450

Universal Dermatology, PLLC, Fairport

15213

University of Pittsburgh Medical Center, Pittsburgh

28100

Università del Piemonte Orientale, Novara

33176

Vista Health Research, LLC, Miami

34761

Dorisca Research Consulting, LLC, Miami

Alpesh D. Desai, DO, PLLC, a Houston company institution, Houston

50100

Dermatology University of Florence, Florence

60208

Northwestern University, Chicago

80131

University of Campania, Napoli

84112

University of Utah, Salt Lake City

94063

Stanford university, Redwood City

01915

ALLCUTIS Research, LLC, Beverly

01844

Allcutis Research, Methuen

Unknown

Universitaria Di Bologna, Bologna

Università degli Studi di Modena e Reggio Emilia, Modena

UOSD Dermatology Oncology, Roma

All Listed Sponsors
lead

Skin Analytics Limited

INDUSTRY